Lion TCR Competitors and Similar CompaniesClear all
Lion TCR's competitors and similar companies include MABION and Adagene.
 Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. | |
Founding Date | Founding Date N/A | Founding Date 2007 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG | Locations Konstantynów Łódzki, PL HQ | Locations Suzhou, CN HQ San Diego, US San Francisco, US |
Employees | Employees N/A | Employees 95 | Employees 13821% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 21.7 m | Valuation ($) 137.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods zł24.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit (zł7.2m) (FY, 2025) | Gross profit $7.7m (FY, 2025) |
Net income | Net income N/A | Net income (zł62.6m) (FY, 2025) | Net income ($17.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 20m | Total funding raised N/A | Total funding raised $ 155m |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyAdagene
HQ
Suzhou, CN
Employees
138↓ 21% decrease
Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
View company